“…Drug delivery technologies have reduced side effects while enhancing biocompatibility, pharmacokinetics, and therapeutic efficacy. 140,141 Due to their comparable homing characteristics or self-expressed signal molecules, biomimetic nanoparticles are very effective at targeting tumors. 142,143 Similarly, because of their inherent existence in vivo, good biocompatibility and lengthy circulation times are simultaneously achieved.…”